However, since RB was injected intravenously before tumors developed into Lgr5-EGFP-IRES-creERT2 knock-in mice that were treated with AOM and DSS, it was distributed equally in Lgr5+ cells that express EGFP and in other cells that do not. This evidence concerns the gene LGR5 and infectious otitis media.